METHOD FOR THE PRODUCTION OF A MONOLITHIC MULTILAYER ACTUATOR, MONOLITHIC MULTILAYER ACTUATOR MADE OF A PIEZOCERAMIC OR ELECTROSTRICTIVE MATERIAL, AND EXTERNAL ELECTRICAL CONTACT FOR A MONOLITHIC MULTILAYER ACTUATOR

Details for Australian Patent Application No. 2003233327 (hide)

Owner PI CERAMIC GMBH KERAMISCHE TECHNOLOGIEN UND BAUELEMENTE

Inventors HEINZMANN, Astrid; HENNIG, Eberhard; KOPSCH, Daniel; PERTSCH, Patrick; RICHTER, Stefan; WEHRSDORFER, Eike

Pub. Number AU-A-2003233327

PCT Number PCT/EP03/05051

PCT Pub. Number WO2003/105246

Priority 102 34 787.5 30.07.02 DE; 102 25 405.2 07.06.02 DE

Filing date 14 May 2003

Wipo publication date 22 December 2003

International Classifications

H01L 041/24 Piezo-electric elements in general - of elements of ceramic composition

H01L 041/083 Piezo-electric elements in general - having a stacked or multilayer structure

H01L 041/047 Piezo-electric elements in general

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 102 34 787.5 30.07.02 DE; 102 25 405.2 07.06.02 DE

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003233327

24 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003233328-A COMMUNICATIONS HEADSET

2003233326-DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH NEUROMEDIN U2 RECEPTOR (NMU2)